Metformin’s Role in Lowering Colorectal Cancer Risk Among Individuals with Diabetes from the Southern Community Cohort Study
Cancer Epidemiology (2024) Authors: Thomas Lawler, Zoe L. Walts, Lauren Giurini, Mark Steinwandel, Loren Lipworth, Harvey J. Murff, Wei Zheng, Shaneda Warren Andersen Abstract: Metformin, utilized to manage hyperglycemia, has been linked to a reduced risk of colorectal cancer (CRC) among individuals with diabetes. However, evidence is lacking for non-Hispanic Black individuals and those with …